Oncology

Investigators with pet health insurer Nationwide examined claims for 1.6 million dogs

Here's our regular rundown of new and notable veterinary products.

The gift will expand the OFA's support of educational grants through CHF's Clinician-Scientist Fellowship Program.

The resource was designed to enhance pet parents’ knowledge surrounding veterinary oncology.

3 videos featuring tips and tricks for treating canine and feline patients with lymphoma.

Crofelemer (Canalevia-CA1) is conditionally approved by the FDA for treatment of chemotherapy-induced diarrhea in dogs and could also be used to treat exercise-induced diarrhea.

The BluePearl Greater Philadelphia network hospitals are offering a funded study evaluating the first-in-class liquid biopsy test from PetDx in 2022.

The study analyzed canine cancer in over 700 dogs across 23 tumor types and can help progress precision cancer therapeutics.

The collaboration will provide IDEXX Reference Laboratories’ veterinary customers access to FidoCure Next Generation DNA Sequencing Test.

In a dvm360® interview, Sue Ettinger, DVM, DACVIM (Oncology), reviewed different variables that may put felines at risk of developing gastrointestinal lymphoma.

At a recent webinar, oncology specialist Dr. Philip Bergman offered his top 10 list of advances that could make a difference for your next cancer patient. (Sponsored by VCA Animal Hospitals)

The collaborative effort makes OncoK9 liquid biopsy available immediately to more veterinary customers

In a dvm360® interview, Sue Ettinger, DVM, DACVIM (Oncology), highlighted discrepancies among dog and cat patients when treating lymphoma with chemotherapy.

Novel liquid biopsy uses blood samples to detect cancer-associated genomic alterations in dogs.

The prescription-only crofelemer delayed-release tablets were developed using a sustainable, plant-based formula.

In a dvm360® interview, Sue Ettinger, DVM, DACVIM (Oncology), highlighted common side effects of chemotherapy treatment in canine and feline patients.

Jenny Fisher, RVT, VTS, described why cytology is an integral tool veterinary practices should be utilizing.

In this video interview with dvm360®, Jenny Fisher, RVT, VTS, offers up invaluable advice to veterinary technicians who are interested in oncology.

The funding will be used to increase the adoption of the company's first-in-class multi-cancer early detection test, OncoK9.

In a dvm360® interview, Sue Ettinger, DVM, DACVIM (Oncology), shared the types of lymphoma and common signs to be mindful of surrounding this condition.

Despite all the advancements in human medicine over the past few decades, veterinary medicine has seen little change until recently. Now, several new therapeutic developments have emerged specifically for use in veterinary medicine that have promising potential in changing how veterinarians treat cancer.

Jenny Fisher, RVT, VTS, outlined the B.A.G. acronym and how it is useful in identifying the body systems affected by chemotherapy and radiation.

Sue Ettinger, DVM, DACVIM (Oncology), disclosed one thing she wants veterinary professionals to know about being an oncology veterinarian, plus shares the benefits one of her patients experienced on chemotherapy.

Check out this week's highlights.

In this video interview with dvm360®, Jenny Fisher, RVT, VTS, reviewed several ways veterinary professionals are treating their patients with cancer.

The case for an increased focus on research at the overlapping boundaries between human and animal health in the area of heart disease.

A sneak peek of this week's headlines.

In a recent dvm360® interview, Jenny Fisher, RVT, VTS, explains 2 common techniques when performing fine needle aspirations and when each is appropriate to use.

As part of National Pet Cancer Awareness Month in November, Nationwide is engaging claims data to offer unique analyses and pledging support for pet cancer research.

During a dvm360® interview, Jenny Fisher, RVT, VTS, discussed the variations between how these tumor types present themselves in both dogs and cats.